Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture (GRASP-DC)
Generating Real-world Ambispective Data to Study Participant Treatment Outcomes for Dupuytren's Contracture
Sponsor: Endo Pharmaceuticals
Terminated
Endo determined to discontinue its registries and the GRASP registry enrollment has been closed.
This observational or N/A phase trial investigates Dupuytren's Contracture and is currently terminated or withdrawn. Endo Pharmaceuticals leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Aug 2025 — Present [monthly]
Terminated
-
Sep 2024 — Aug 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
May 2024 — Jul 2024 [monthly]
Terminated
Status: Recruiting → Terminated
-
Mar 2024 — May 2024 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Oct 2023 — Mar 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2023 — Oct 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Endo Pharmaceuticals
- Pulse Infoframe
For direct contact, visit the study record on ClinicalTrials.gov .